Aptose Biosciences Inc banner
A

Aptose Biosciences Inc
TSX:APS

Watchlist Manager
Aptose Biosciences Inc
TSX:APS
Watchlist
Price: 2.4 CAD
Market Cap: CA$43.5m

Wall St Price Targets

APS Price Targets Summary
Aptose Biosciences Inc

There are no price targets for APS.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Aptose Biosciences Inc Competitors:
Price Targets
QXO
SilverSun Technologies Inc
128% Upside
FULT
Fulton Financial Corp
-2% Downside
ZEAL
Zealand Pharma A/S
71% Upside
LGI
Lgi Ltd
94% Upside
EOLS
Evolus Inc
158% Upside
INO
Inovio Pharmaceuticals Inc
218% Upside
PRQR
ProQR Therapeutics NV
388% Upside
NWSA
News Corp
30% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is APS's stock price target?
Not Available

APS does not have any price targets made by Wall Street professionals.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett